Respiratory and Pulmonary Pharmacotherapy
Respiratory and Pulmonary Pharmacotherapy
Respiratory and pulmonary pharmacotherapy focuses on the management of diseases and conditions affecting the lungs and respiratory system. These include asthma, chronic obstructive pulmonary disease (COPD), pulmonary hypertension, cystic fibrosis, and infections like pneumonia and tuberculosis. The goal of pharmacotherapy is to relieve symptoms, improve lung function, prevent exacerbations, and enhance overall quality of life.
Related Conference of Respiratory and Pulmonary Pharmacotherapy
Respiratory and Pulmonary Pharmacotherapy Conference Speakers
Recommended Sessions
- Advanced Drug Delivery Systems
- Advances in Vaccine Technology
- Advances in Omics Technologies
- Artificial Intelligence in Biomedicine
- Biotechnology in Drug Development
- Cardiovascular Pharmacotherapy
- Clinical Pharmacology and Therapeutics
- Digital Health and Telemedicine
- Ethical Challenges and Regulatory Science in Healthcare and Pharmaceuticals
- Gene Therapy and Genetic Medicine
- Immunotherapy and Immunopharmacology
- Infectious Diseases and Antimicrobial Resistance
- Innovations in Biologics and Biosimilars
- Metabolic Disorders and Endocrinology
- Nanotechnology in Biomedicine
- Neuropharmacology and Neurotherapeutics
- Oncology Research and Therapeutics
- Paediatric and Geriatric Pharmacotherapy
- Pharmacogenomics and Personalized Medicine
- Pharmacovigilance and Drug Safety
- Public Health and Pharmacoeconomics
- Rare and Orphan Diseases: Therapeutic Approaches
- Rare Disease Therapeutics
- Regenerative Medicine and Tissue Engineering
- Respiratory and Pulmonary Pharmacotherapy